Relatedness of medically important strains of Saccharomyces cerevisiae as revealed by phylogenetics and metabolomics
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Ten medically important Saccharomyces strains, comprising six clinical isolates of Saccharomyces cerevisiae and four probiotic strains of Saccharomyces boulardii, were characterized at the genetic and metabolic level and compared with non‐medical, commercial yeast strains used in baking and wine‐making. Strains were compared by genetic fingerprinting using amplified fragment length polymorphism (AFLP) analysis, by ribosomal DNA ITS1 sequencing and by metabolic footprinting using both direct injection mass spectrometry (DIMS) and gas chromatography–time of flight–mass spectrometry (GC–ToF–MS). Overall, the clinical isolates fell into different groupings when compared with the non‐medical strains, with good but not perfect correlation amongst strains at both the genetic and metabolic levels. Probiotic strains of S. boulardii that are used therapeutically to treat human gastro‐intestinal tract disorders showed tight clustering both genetically and metabolically. Metabolomics was found to be of value both as a taxonomic tool and as a means to investigate anomalous links between genotype and phenotype. Key discriminatory metabolites were identified when comparing the three main groups of clinical, probiotic and non‐medical strains and included molecules such as trehalose, myo‐inositol, lactic acid, fumaric acid and glycerol 3‐phosphate. This study confirmed the link between a subset of clinical isolates and baking or probiotic strains but also highlighted that in general the clinical strains were more diverse at both the genomic and metabolic levels. Copyright © 2008 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-Scale Reconstruction of the Saccharomyces cerevisiae Metabolic Network
Förster, J., Famili, I., Fu, P., Palsson, B. Ø., & Nielsen, J. (2003) · Genome Research · doi:10.1101/gr.234503 · Cited by 1,069 · cited 2×
“In the present study, we have shown that DIMS may therefore be more appropriate for the rapid screening and classification of large numbers of samples, whereas GC–MS may be more relevant in identifying and quantifying discriminatory metabolites for ‘biological reasoning’ in the analysis of metabolic networks (Blank et…”
BackgroundSaccharomyces cerevisiae Fungemia: An Emerging Infectious Disease
Munoz, P., Bouza, E., Cuenca-Estrella, M., Eiros, J. M., Perez, M. J., Sanchez-Somolinos, M., Rincon, C., Hortal, J., & Pelaez, T. (2005) · Clinical Infectious Diseases · doi:10.1086/429916 · Cited by 462 · cited 6×
“The link between the use of S. boulardii as a probiotic in immunocompromised or severely debilitated patients and the occurrence of fungaemia has been more or less proven, which has led to the withdrawal of this treatment in these cases (Muñoz et al., 2005).”
BackgroundInfluentialMetabolic-flux and network analysis in fourteen hemiascomycetous yeasts
BLANK, L., LEHMBECK, F., & SAUER, U. (2005) · FEMS Yeast Research · doi:10.1016/j.femsyr.2004.09.008 · Cited by 217
Cited by
The Human Serum Metabolome (HUSERMET) Consortium, Dunn, W. B., Broadhurst, D., Begley, P., Zelena, E., Francis-McIntyre, S., Anderson, N., Brown, M., Knowles, J. D., Halsall, A., et al. (2011) · Nature Protocols · doi:10.1038/nprot.2011.335 · Cited by 3,294
Self-citationCharacterization of the oral fungal microbiome (mycobiome) in healthy individuals
Ghannoum, M. A., Jurevic, R. J., Mukherjee, P. K., Cui, F., Sikaroodi, M., Naqvi, A., & Gillevet, P. M. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000713 · Cited by 1,150
“To obtain a more comprehensive profile of the fungal microbiome (mycobiome), in this study we utilized a novel Multitag Pyrosequencing (MTPS) approach to interrogate the fungal taxa in the oral cavity using universal internal transcribed spacer (ITS) primers, which have broad fungal specificity [5–13].”
MethodEnvironmental metabolomics: a critical review and future perspectives
Bundy, J. G., Davey, M. P., & Viant, M. R. (2009) · Metabolomics · doi:10.1007/s11306-008-0152-0 · Cited by 812
Metabolomic analysis in food science: a review
Cevallos-Cevallos, J. M., Reyes-De-Corcuera, J. I., Etxeberria, E., Danyluk, M. D., & Rodrick, G. E. (2009) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2009.07.002 · Cited by 545
Systematic review and meta-analysis of Saccharomyces boulardii in adult patients
McFarland, L. V. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i18.2202 · Cited by 545
Metadata
- Authors
- MacKenzie, D. A., Defernez, M., Dunn, W. B., Brown, M., Fuller, L. J., de Herrera, S. R. M. S., Günther, A., James, S. A., Eagles, J., Philo, M., Goodacre, R., & Roberts, I. N.
- Venue
- Yeast
- Publisher
- Wiley
- Published
- 2008-07
- Volume
- 25
- Issue
- 7
- Pages
- 501-512
- ISSN
- 0749-503X (ISSN-L)
- 1097-0061
- OpenAlex
- W2139947577
- Cited by
- 51
- References
- 3
- FWCI
- 2.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.